Fc and Complement Receptors

Molecular Biology of B Cells

Volumn , Issue , 2004, Pages 275-287

  Ravetch, Jeffrey V ^a   Carroll, Michael C ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84941712554     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012053641-2/50019-8     Document Type: Chapter

References (63)

1. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998, 16:545-568.
2. Ravetch J.V. Fc receptors. Fundamental immunology 2003, Lippincott-Raven, Philadelphia-New York. 5th ed. W. Paul (Ed.).
3. Takai T., et al. Augmented humoral and anaphylactic responses in Fc-gamma-RII-deficient mice. Nature 1996, 379(6563):346-349.
4. Bolland S., Ravetch J.V. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000, 13(2):277-285.
5. Nakamura A., et al. Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: A novel murine model for autoimmune glomerular basement membrane disease. J Exp Med 2000, 191(5):899-906.
6. Yuasa T., et al. Deletion of Fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med 1999, 189(1):187-194.
7. Pritchard N.R., et al. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FegammaRII. Curr Biol 2000, 10(4):227-230.
8. Jiang Y., et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 2000, 51(6):429-435.
9. Wakeland E.K., et al. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001, 15(3):397-408.
10. Carter R.H., Fearon D.T. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992, 256(5053):105-107.
11. Rao S.P., Vora K.A., Manser T. Differential expression of the inhibitory IgG Fc receptor FcgammaRIIB on germinal center cells: Implications for selection of high-affinity B cells. J Immunol 2002, 169(4):1859-1868.
12. de Andrés B., et al. FcγRII (CD32) is linked to apoptotic pathways in murine granulocyte precursors and mature eosinophils. Blood 1997, 90(3):1267-1274.
13. Kalergis A.M., Ravetch J.V. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med 2002, 195(12):1653-1659.
14. Amigorena S., et al. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 1992, 256(5065):1808-1812.
15. Muta T., et al. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature 1994, 369(6478):340.
16. Ono M., et al. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 1996, 383(6597):263-266.
17. Tridandapani S., et al. Protein interactions of Src homology 2 (SH2) domain-containing inositol phosphatase (SHIP): Association with Shc displaces SHIP from FcγRIIb in B cells. J Immunol 1999, 162(3):1408-1414.
18. Daeron M., et al. The same tyrosine-based inhibition motif. in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 1995, 3(5):635-646.
19. Bolland S., et al. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 1998, 8(4):509-516.
20. Tamir I., et al. The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity 2000, 12(3):347-358.
21. Yamanashi Y., et al. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. Genes Dev 2000, 14(1):11-16.
22. Aman M.J., et al. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J Biol Chem 1998, 273(51):33922-33928.
23. Liu Q., et al. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev 1999, 13(7):786-791.
24. Pearse R.N., et al. SHIP recruitment attenuates FcγRIIB-induced B cell apoptosis. Immunity 1999, 10(6):753-760.
25. MacLennan I.C. Germinal centers. Annu Rev Immunol 1994, 12:117-139.
26. Tew J.G., et al. Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells. Immunol Rev 1997, 156:39-52.
27. Barrington R.A., et al. B lymphocyte memory: Role of stromal cell complement and FcgammaRIIB receptors. J Exp Med 2002, 196(9):1189-1199.
28. Barrington R., et al. The role of complement in inflammation and adaptive immunity. Immunol Rev 2001, 180:5-15.
29. Tew J.G., et al. Follicular dendritic cells: Beyond the necessity of T-cell help. Trends Immunol 2001, 22(7):361-367.
30. Bruggemann M., Rajewsky K. Regulation of the antibody response against hapten-coupled erythrocytes by monoclonal antihapten antibodies of various isotypes. Cell Immunol 1982, 71(2):365-373.
31. Heyman B., Wigzell H. Immunoregulation by monoclonal sheep erythrocyte-specific IgG antibodies: suppression is correlated to level of antigen binding and not to isotype. J Immunol 1984, 132(3):1136-1143.
32. Bowman J.M. The prevention of Rh immunization. Transfus Med Rev 1988, 2(3):129-150.
33. Karlsson M.C.I., Getahun A., Heyman B. FcγRIIB in IgG-mediated suppression of antibody responses: Different impact in vivo and in vitro. J Immunol 2001, 167(10):5558-5564.
34. Kumpel B.M. In vivo studies of monoclonal anti-D and the mechanism of immune suppression. Transfus Clin Biol 2002, 9(1):9-14.
35. Heyman B. Regulation of antibody responses via antibodies, complement and Fc-receptors. Annu Rev Immunol 2000, 18:709-737.
36. Regnault A., et al. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 1999, 189(2):371-380.
37. Wernersson S., et al. IgG-mediated enhancement of Ab responses is low in FcRγ chain deficient mice and increased in FcγRII deficient mice. J Immunol 1999, 163:618-622.
38. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673):245-252.
39. Reid K.B., Porter R.R. The proteolytic activation systems of complement. Annu Rev Biochem 1981, 50:433-464.
40. Muller-Eberhard H.J. Molecular organization and function of the complement system. Annu Rev Biochem 1998, 57:321-347.
41. Fearon D.T., Carroll M.C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 2000, 18:393-422.
42. Nussenzweig V., et al. Receptors for C3 on B lymphocytes: Possible role in the immune response. Progress in immunology 1971, 73. Academic Press, New York. B. Amos (Ed.).
43. Pepys M.B. Role of complement in induction of the allergic response. Nat New Biol 1972, 237(74):157-159.
44. Carroll M.C. The role of complement in B cell activation and tolerance. Adv Immunol 2000, 74:61-88.
45. Kurtz C.B., et al. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J Immunol 1990, 144(9):3581-3591.
46. Molina H., et al. A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. J Immunol 1990, 145(9):2974-2983.
47. Carter R.H., Fearon D.T. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992, 256(5053):105-107.
48. Hebell T., Ahearn J.M., Fearon D.T. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 1991, 254(5028):102-105.
49. Gustavsson S., Kinoshita T., Heyman B. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J Immunol 1995, 154(12):6524-6528.
50. Ahearn J.M., et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 1996, 4(3):251-262.
51. Fang Y., et al. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol 1998, 160(11):5273-5279.
52. Hardy R.R., Hayakawa K. B cell development pathways. Annu Rev Immunol 2001, 19:595-621.
53. Herzenberg L.A. B-1 cells: the lineage question revisited. Immunol Rev 2000, 175:9-22.
54. Cariappa A., Pillai S. Antigen-dependent B-cell development. Curr Opin Immunol 2002, 14(2):241-249.
55. Fleming S.D., et al. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 2002, 169(4):2126-2133.
56. Reid R., et al. Functional activity of natural antibody is altered in Cr2null mice. J Immunol 2002, 169(10):5433-5440.
57. Fischer M.B., et al. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 1998, 280(5363):582-585.
58. MacLennan I.C. Germinal centers. Annu Rev Immunol 1994, 12:117-139.
59. Fischer M.B., et al. Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice. J Immunol 1998, 160(6):2619-2625.
60. Gray D. A role for antigen in the maintenance of immunological memory. Nat Rev Immunol 2002, 2(1):60-65.
61. Boackle S.A., et al. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 2001, 15(5):775-785.
62. Cutler A.J., et al. Intact B cell tolerance in the absence of the first component of the classical complement pathway. Eur J Immunol 2001, 31(7):2087-2093.
63. Prodeus A.P., et al. A critical role for complement in maintenance of self-tolerance. Immunity 1998, 9(5):721-731.